Showing results (31-40 of 92) with videos related to

Sort By:
Pageof 10
Seminars in Cancer Biology|July 30, 2018
Challenges and opportunities in the proteomic characterization of clear cell renal cell carcinoma (ccRCC): A critical step towards the personalized care of renal cancersQing Kay Li, Christian P Pavlovich, Hui Zhang, et al.
Clinical Proteomics|October 24, 2024
SPOT: spatial proteomics through on-site tissue-protein-labelingYuanwei Xu, T Mamie Lih, Angelo M De Marzo, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 7, 2017
Heterogeneous expression of PD-L1 in pulmonary squamous cell carcinoma and adenocarcinoma: implications for assessment by small biopsyThomas J Gniadek, Qing Kay Li, Ellen Tully, et al.
Clinical Proteomics|November 2, 2013
Aberrant Mucin5B expression in lung adenocarcinomas detected by iTRAQ labeling quantitative proteomics and immunohistochemistryYan Li, Xiangchun Wang, Minghui Ao, et al.
Nature Protocols|February 17, 2025
Sonication-assisted protein extraction improves proteomic detection of membrane-bound and DNA-binding proteins from tumor tissuesQing Kay Li, T Mamie Lih, David J Clark, et al.
Clinical Proteomics|December 3, 2013
Epithelium percentage estimation facilitates epithelial quantitative protein measurement in tissue specimensJing Chen, Shadi Toghi Eshghi, George Steven Bova, et al.
Human Pathology|April 19, 2011
EGFR and KRAS mutations in metastatic lung adenocarcinomasDelicia Munfus-McCray, Shuko Harada, Christina Adams, et al.
Cancer Cytopathology|September 11, 2010
The utility of napsin-A in the identification of primary and metastatic lung adenocarcinoma among cytologically poorly differentiated carcinomasLisa M Stoll, Michael W Johnson, Edward Gabrielson, et al.
Translational Respiratory Medicine|October 28, 2014
Expression of transcript factors SALL4 and OCT4 in a subset of non-small cell lung carcinomas (NSCLC)Erika Rodriguez, Li Chen, Ming-Hui Ao, et al.
Human Pathology|November 12, 2025
Cytopathologic and histopathologic characteristics of SMARCB1 deficient neoplasm and correlation with molecular and immunohistochemical findingsSandra Ixchel Sanchez, Christina Adams, Peter Illei, et al.
Pageof 10